Classification of stool consistency (types 1–7)
Primary source: Lewis SJ, Heaton KW. Scand J Gastroenterol 1997; 32(9): 920-924
The Bristol Stool Form Scale (Heaton KW et al., Scand J Gastroenterol 1997) is a standardized visual-descriptive scale developed at the University of Bristol to assess stool form and consistency. It is used in gastroenterology, infectious disease medicine, and general practice to objectify patient-reported symptoms.
The scale comprises 7 types: type 1 - separate hard lumps ("nuts", severe constipation); type 2 - sausage-shaped but lumpy (constipation); type 3 - sausage-shaped with cracks on the surface (normal); type 4 - smooth, soft, like a sausage or snake (normal, optimal); type 5 - soft blobs with clear-cut edges (tendency toward diarrhea); type 6 - fluffy pieces with ragged edges (diarrhea); type 7 - watery, no solid pieces (severe diarrhea).
Used in the diagnosis of IBS (classification into IBS-C/IBS-D/IBS-M per Bristol), assessment of laxative and antidiarrheal efficacy, severity assessment of infectious diarrhea, and monitoring of patients with diverticulosis, CKD, or in palliative care. The Bristol scale is included in the Rome IV criteria for IBS as a standard tool for documenting stool form.
Stool type is determined visually or from patient report using an illustrated chart of the scale. Documented as "Bristol type 3", etc.
Woman, 38 years old, with abdominal pain and altered bowel habits for one year. Bowel movements 4-5 times per week, Bristol type 1-2 (hard lumps, like nuts, or lumpy sausage-shaped stool), often with straining. Pain decreases after defecation.
Bristol 1-2 — predominance of hard, formed stool.
IBS with constipation (IBS-C) per Rome IV criteria (≥25% of bowel movements Bristol 1-2 and <25% Bristol 6-7). Management: exclude red flags (weight loss, blood in stool, nocturnal symptoms, family history of colorectal cancer, especially in patients >45 years), CBC and metabolic panel, CRP, fecal calprotectin, TSH. After excluding organic disease: diet (FODMAP restriction for 4-6 weeks), osmotic laxatives (polyethylene glycol), and if response is inadequate, linaclotide or prucalopride. Psychotherapy (CBT) has an evidence base in IBS-C.
Validated scores and formulas with full interpretation, clinical examples and source references. Open access, no registration required.
65+ calculators · scores and formulas · interpretation with management notes